{
    "abstract": "Background: Attenuated vaccinia virus strain, LC16m8, defective in the B5R envelope protein gene, is used as a stockpile smallpox vaccine strain in Japan against bioterrorism: the defect in the B5R gene mainly contributes to its highly attenuated properties. Methods: The protective activity of LC16m8 vaccine against challenge with a lethal dose of vaccinia Western Reserve strain was assessed in wild-type and immunodeficient mice lacking CD4, MHC class I, MHC class II or MHC class I and II antigens. Results: The immunization with LC16m8 induced strong protective activity comparable to that of its parent strain, Lister (Elstree) strain, in wild-type mice from 2 days to 1 year after vaccination, as well as in immunodeficient mice at 2 or 3 weeks after vaccination. These results implicated that the defect in the B5R gene hardly affected the potential activity of LC16m8 to induce innate, cell-mediated and humoral immunity, and that LC16m8 could be effective in immunodeficient patients. Conclusion: LC16m8 with truncated B5 protein has an activity to induce immunity, such as innate immunity and subsequent cell-mediated and humoral immunity almost completely comparable to the activity of its parental strain Lister.",
    "bib_entries": {
        "bib0145": {
            "authors": [
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Chen"
                },
                {
                    "first": "J. Michael",
                    "initial": "J.M.",
                    "last": "Lane"
                }
            ],
            "doi": "10.1016/S0140-6736(03)14674-0",
            "firstpage": "1345",
            "issn": "01406736",
            "lastpage": "1346",
            "pmid": "14585633",
            "pub_year": 2003,
            "title": "Myocarditis: The unexpected return of smallpox vaccine adverse events",
            "volume": "362"
        },
        "bib0150": {
            "authors": [
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Enserink"
                }
            ],
            "firstpage": "809",
            "issn": "00368075",
            "pmid": "15131277",
            "pub_year": 2004,
            "title": "Smallpox Vaccines: Looking Beyond the Next Generation",
            "volume": "304"
        },
        "bib0155": {
            "authors": [
                {
                    "first": "Igor M.",
                    "initial": "I.M.",
                    "last": "Belyakov"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Earl"
                },
                {
                    "first": "Amiran",
                    "initial": "A.",
                    "last": "Dzutsev"
                },
                {
                    "first": "Vladimir A.",
                    "initial": "V.A.",
                    "last": "Kuznetsov"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Lemon"
                },
                {
                    "first": "Linda S.",
                    "initial": "L.S.",
                    "last": "Wyatt"
                },
                {
                    "first": "James T.",
                    "initial": "J.T.",
                    "last": "Snyder"
                },
                {
                    "first": "Jeffrey D.",
                    "initial": "J.D.",
                    "last": "Ahlers"
                },
                {
                    "first": "Genoveffa",
                    "initial": "G.",
                    "last": "Franchini"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Moss"
                },
                {
                    "first": "Jay A.",
                    "initial": "J.A.",
                    "last": "Berzofsky"
                }
            ],
            "doi": "10.1073/pnas.1233578100",
            "firstpage": "9458",
            "issn": "00278424",
            "lastpage": "9463",
            "pmid": "12869693",
            "pub_year": 2003,
            "title": "Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses",
            "volume": "100"
        },
        "bib0160": {
            "authors": [
                {
                    "first": "Patricia L.",
                    "initial": "P.L.",
                    "last": "Earl"
                },
                {
                    "first": "Jeffrey L.",
                    "initial": "J.L.",
                    "last": "Americo"
                },
                {
                    "first": "Linda S.",
                    "initial": "L.S.",
                    "last": "Wyatt"
                },
                {
                    "first": "Leigh Anne",
                    "initial": "L.A.",
                    "last": "Eller"
                },
                {
                    "first": "J. Charles",
                    "initial": "J.C.",
                    "last": "Whitbeck"
                },
                {
                    "first": "Gary H.",
                    "initial": "G.H.",
                    "last": "Cohen"
                },
                {
                    "first": "Roselyn J.",
                    "initial": "R.J.",
                    "last": "Eisenberg"
                },
                {
                    "first": "Christopher J.",
                    "initial": "C.J.",
                    "last": "Hartmann"
                },
                {
                    "first": "David L.",
                    "initial": "D.L.",
                    "last": "Jackson"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Kulesh"
                },
                {
                    "first": "Mark J.",
                    "initial": "M.J.",
                    "last": "Martinez"
                },
                {
                    "first": "David M.",
                    "initial": "D.M.",
                    "last": "Miller"
                },
                {
                    "first": "Eric M.",
                    "initial": "E.M.",
                    "last": "Mucker"
                },
                {
                    "first": "Joshua D.",
                    "initial": "J.D.",
                    "last": "Schamblin"
                },
                {
                    "first": "Susan H.",
                    "initial": "S.H.",
                    "last": "Zwiers"
                },
                {
                    "first": "John W.",
                    "initial": "J.W.",
                    "last": "Huggins"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Jahrting"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Moss"
                }
            ],
            "doi": "10.1038/nature02331",
            "firstpage": "182",
            "issn": "00280836",
            "lastpage": "185",
            "pmid": "15014500",
            "pub_year": 2004,
            "title": "Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox",
            "volume": "428"
        },
        "bib0165": null,
        "bib0170": null,
        "bib0175": {
            "authors": [],
            "firstpage": "1",
            "issn": "00498114",
            "lastpage": "20",
            "pmid": "24466571",
            "pub_year": 2014,
            "title": "Meeting of the Strategic Advisory Group of Experts on immunization, November 2013 -- conclusions and recommendations.",
            "volume": "89"
        },
        "bib0180": {
            "authors": [
                {
                    "first": "Fukumi",
                    "initial": "F.",
                    "last": "Takahashi-Nishimaki"
                },
                {
                    "first": "Shin Ichi",
                    "initial": "S.I.",
                    "last": "Funahashi"
                },
                {
                    "first": "Keizaburo",
                    "initial": "K.",
                    "last": "Miki"
                },
                {
                    "first": "So",
                    "initial": "S.",
                    "last": "Hashizume"
                },
                {
                    "first": "Masanobu",
                    "initial": "M.",
                    "last": "Sugimoto"
                }
            ],
            "doi": "10.1016/0042-6822(91)90480-Y",
            "firstpage": "158",
            "issn": "00426822",
            "lastpage": "164",
            "pmid": "1994573",
            "pub_year": 1991,
            "title": "Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins",
            "volume": "181"
        },
        "bib0185": {
            "authors": [
                {
                    "first": "Geoffrey L.",
                    "initial": "G.L.",
                    "last": "Smith"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Vanderplasschen"
                },
                {
                    "first": "Mansun",
                    "initial": "M.",
                    "last": "Law"
                }
            ],
            "doi": "10.1099/0022-1317-83-12-2915",
            "firstpage": "2915",
            "issn": "00221317",
            "lastpage": "2931",
            "pmid": "12466468",
            "pub_year": 2002,
            "title": "The formation and function of extracellular enveloped vaccinia virus",
            "volume": "83"
        },
        "bib0190": {
            "authors": [
                {
                    "first": "Shigeru",
                    "initial": "S.",
                    "last": "Morikawa"
                },
                {
                    "first": "Tokuki",
                    "initial": "T.",
                    "last": "Sakiyama"
                },
                {
                    "first": "Hideki",
                    "initial": "H.",
                    "last": "Hasegawa"
                },
                {
                    "first": "Masayuki",
                    "initial": "M.",
                    "last": "Saijo"
                },
                {
                    "first": "Akihiko",
                    "initial": "A.",
                    "last": "Maeda"
                },
                {
                    "first": "Ichiro",
                    "initial": "I.",
                    "last": "Kurane"
                },
                {
                    "first": "Go",
                    "initial": "G.",
                    "last": "Maeno"
                },
                {
                    "first": "Junko",
                    "initial": "J.",
                    "last": "Kimura"
                },
                {
                    "first": "Chie",
                    "initial": "C.",
                    "last": "Hirama"
                },
                {
                    "first": "Teruhiko",
                    "initial": "T.",
                    "last": "Yoshida"
                },
                {
                    "first": "Yasuko",
                    "initial": "Y.",
                    "last": "Asahi-Ozaki"
                },
                {
                    "first": "Tetsutaro",
                    "initial": "T.",
                    "last": "Sata"
                },
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Kurata"
                },
                {
                    "first": "Asato",
                    "initial": "A.",
                    "last": "Kojima"
                }
            ],
            "doi": "10.1128/JVI.79.18.11873-11891.2005",
            "firstpage": "11873",
            "issn": "0022538X",
            "lastpage": "11891",
            "pmid": "16140764",
            "pub_year": 2005,
            "title": "An attenuated LC16m8 smallpox vaccine: Analysis of full-genome sequence and induction of immune protection",
            "volume": "79"
        },
        "bib0195": {
            "authors": [
                {
                    "first": "Clement A.",
                    "initial": "C.A.",
                    "last": "Meseda"
                },
                {
                    "first": "Anne E.",
                    "initial": "A.E.",
                    "last": "Mayer"
                },
                {
                    "first": "Arunima",
                    "initial": "A.",
                    "last": "Kumar"
                },
                {
                    "first": "Alonzo D.",
                    "initial": "A.D.",
                    "last": "Garcia"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Campbell"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Listrani"
                },
                {
                    "first": "Jody",
                    "initial": "J.",
                    "last": "Manischewitz"
                },
                {
                    "first": "Lisa R.",
                    "initial": "L.R.",
                    "last": "King"
                },
                {
                    "first": "Hana",
                    "initial": "H.",
                    "last": "Golding"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Merchlinsky"
                },
                {
                    "first": "Jerry P.",
                    "initial": "J.P.",
                    "last": "Weir"
                }
            ],
            "doi": "10.1128/CVI.00040-09",
            "firstpage": "1261",
            "issn": "15566811",
            "lastpage": "1271",
            "pmid": "19605597",
            "pub_year": 2009,
            "title": "Comparative evaluation of the immune responses and protection engendered by LC16m8 and dryvax smallpox vaccines in a mouse model",
            "volume": "16"
        },
        "bib0200": {
            "authors": [
                {
                    "first": "Marie C.",
                    "initial": "M.C.",
                    "last": "Galmiche"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Goenaga"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Wittek"
                },
                {
                    "first": "Lorenz",
                    "initial": "L.",
                    "last": "Rindisbacher"
                }
            ],
            "doi": "10.1006/viro.1998.9516",
            "firstpage": "71",
            "issn": "00426822",
            "lastpage": "80",
            "pmid": "9927575",
            "pub_year": 1999,
            "title": "Neutralizing and protective antibodies directed against vaccinia virus envelope antigens",
            "volume": "254"
        },
        "bib0205": {
            "authors": [
                {
                    "first": "Benjamin F.",
                    "initial": "B.F.",
                    "last": "Johnson"
                },
                {
                    "first": "Yasuhiro",
                    "initial": "Y.",
                    "last": "Kanatani"
                },
                {
                    "first": "Tatsuya",
                    "initial": "T.",
                    "last": "Fujii"
                },
                {
                    "first": "Tomoya",
                    "initial": "T.",
                    "last": "Saito"
                },
                {
                    "first": "Hiroyuki",
                    "initial": "H.",
                    "last": "Yokote"
                },
                {
                    "first": "Geoffrey L.",
                    "initial": "G.L.",
                    "last": "Smith"
                }
            ],
            "doi": "10.1099/vir.0.034207-0",
            "firstpage": "2405",
            "issn": "00221317",
            "lastpage": "2410",
            "pmid": "21715598",
            "pub_year": 2011,
            "title": "Serological responses in humans to the smallpox vaccine LC16m8",
            "volume": "92"
        },
        "bib0210": {
            "authors": [
                {
                    "first": "Masayuki",
                    "initial": "M.",
                    "last": "Saijo"
                },
                {
                    "first": "Yasushi",
                    "initial": "Y.",
                    "last": "Ami"
                },
                {
                    "first": "Yuriko",
                    "initial": "Y.",
                    "last": "Suzaki"
                },
                {
                    "first": "Noriyo",
                    "initial": "N.",
                    "last": "Nagata"
                },
                {
                    "first": "Naoko",
                    "initial": "N.",
                    "last": "Iwata"
                },
                {
                    "first": "Hideki",
                    "initial": "H.",
                    "last": "Hasegawa"
                },
                {
                    "first": "Momoko",
                    "initial": "M.",
                    "last": "Ogata"
                },
                {
                    "first": "Shuetsu",
                    "initial": "S.",
                    "last": "Fukushi"
                },
                {
                    "first": "Tetsuya",
                    "initial": "T.",
                    "last": "Mizutani"
                },
                {
                    "first": "Tetsutaro",
                    "initial": "T.",
                    "last": "Sata"
                },
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Kurata"
                },
                {
                    "first": "Ichiro",
                    "initial": "I.",
                    "last": "Kurane"
                },
                {
                    "first": "Shigeru",
                    "initial": "S.",
                    "last": "Morikawa"
                }
            ],
            "doi": "10.1128/JVI.02642-05",
            "firstpage": "5179",
            "issn": "0022538X",
            "lastpage": "5188",
            "pmid": "16698998",
            "pub_year": 2006,
            "title": "LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox",
            "volume": "80"
        },
        "bib0215": {
            "authors": [
                {
                    "first": "Minoru",
                    "initial": "M.",
                    "last": "Kidokoro"
                },
                {
                    "first": "Masato",
                    "initial": "M.",
                    "last": "Tashiro"
                },
                {
                    "first": "Hisatoshi",
                    "initial": "H.",
                    "last": "Shida"
                }
            ],
            "doi": "10.1073/pnas.0406671102",
            "firstpage": "4152",
            "issn": "00278424",
            "lastpage": "4157",
            "pmid": "15753319",
            "pub_year": 2005,
            "title": "Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8",
            "volume": "102"
        },
        "bib0220": {
            "authors": [
                {
                    "first": "Hiroyuki",
                    "initial": "H.",
                    "last": "Yokote"
                },
                {
                    "first": "Yasuhiko",
                    "initial": "Y.",
                    "last": "Shinmura"
                },
                {
                    "first": "Tomomi",
                    "initial": "T.",
                    "last": "Kanehara"
                },
                {
                    "first": "Shinichi",
                    "initial": "S.",
                    "last": "Maruno"
                },
                {
                    "first": "Masahiko",
                    "initial": "M.",
                    "last": "Kuranaga"
                },
                {
                    "first": "Hajime",
                    "initial": "H.",
                    "last": "Matsui"
                },
                {
                    "first": "So",
                    "initial": "S.",
                    "last": "Hashizume"
                }
            ],
            "doi": "10.1128/CVI.00199-14",
            "firstpage": "1261",
            "issn": "15566811",
            "lastpage": "1266",
            "pmid": "24990910",
            "pub_year": 2014,
            "title": "Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice",
            "volume": "21"
        },
        "bib0225": {
            "authors": [
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Parker"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Nuara"
                },
                {
                    "first": "R. Mark L.",
                    "initial": "R.M.L.",
                    "last": "Buller"
                },
                {
                    "first": "Denise A.",
                    "initial": "D.A.",
                    "last": "Schultz"
                }
            ],
            "doi": "10.2217/17460913.2.1.17",
            "firstpage": "17",
            "issn": "17460913",
            "lastpage": "34",
            "pmid": "17661673",
            "pub_year": 2007,
            "title": "Human monkeypox: An emerging zoonotic disease",
            "volume": "2"
        },
        "bib0230": {
            "authors": [
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Moss"
                }
            ],
            "doi": "10.1111/j.1600-065X.2010.00975.x",
            "firstpage": "8",
            "issn": "01052896",
            "lastpage": "26",
            "pmid": "21198662",
            "pub_year": 2011,
            "title": "Smallpox vaccines: Targets of protective immunity",
            "volume": "239"
        },
        "bib0235": {
            "authors": [
                {
                    "first": "Magdalini",
                    "initial": "M.",
                    "last": "Moutaftsi"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Tscharke"
                },
                {
                    "first": "Kerrie",
                    "initial": "K.",
                    "last": "Vaughan"
                },
                {
                    "first": "David M.",
                    "initial": "D.M.",
                    "last": "Koelle"
                },
                {
                    "first": "Lawrence",
                    "initial": "L.",
                    "last": "Stern"
                },
                {
                    "first": "Mauricio",
                    "initial": "M.",
                    "last": "Calvo-Calle"
                },
                {
                    "first": "Francis",
                    "initial": "F.",
                    "last": "Ennis"
                },
                {
                    "first": "Masanori",
                    "initial": "M.",
                    "last": "Terajima"
                },
                {
                    "first": "Gerd",
                    "initial": "G.",
                    "last": "Sutter"
                },
                {
                    "first": "Shane",
                    "initial": "S.",
                    "last": "Crotty"
                },
                {
                    "first": "Ingo",
                    "initial": "I.",
                    "last": "Drexler"
                },
                {
                    "first": "Genoveffa",
                    "initial": "G.",
                    "last": "Franchini"
                },
                {
                    "first": "Jon W.",
                    "initial": "J.W.",
                    "last": "Yewdell"
                },
                {
                    "first": "Steven R.",
                    "initial": "S.R.",
                    "last": "Head"
                },
                {
                    "first": "Janice",
                    "initial": "J.",
                    "last": "Blum"
                },
                {
                    "first": "Bjoern",
                    "initial": "B.",
                    "last": "Peters"
                },
                {
                    "first": "Alex",
                    "initial": "A.",
                    "last": "Sette"
                }
            ],
            "doi": "10.2217/fmb.09.110",
            "firstpage": "221",
            "issn": "17460913",
            "lastpage": "239",
            "pmid": "20143946",
            "pub_year": 2010,
            "title": "Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens",
            "volume": "5"
        },
        "bib0240": {
            "authors": [
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Oseroff"
                },
                {
                    "first": "Ferdynand",
                    "initial": "F.",
                    "last": "Kos"
                },
                {
                    "first": "Huynh Hoa",
                    "initial": "H.H.",
                    "last": "Bui"
                },
                {
                    "first": "Bjoern",
                    "initial": "B.",
                    "last": "Peters"
                },
                {
                    "first": "Valerie",
                    "initial": "V.",
                    "last": "Pasquetto"
                },
                {
                    "first": "Jean",
                    "initial": "J.",
                    "last": "Glenn"
                },
                {
                    "first": "Tara",
                    "initial": "T.",
                    "last": "Palmore"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Sidney"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Tscharke"
                },
                {
                    "first": "Jack R.",
                    "initial": "J.R.",
                    "last": "Bennink"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Southwood"
                },
                {
                    "first": "Howard M.",
                    "initial": "H.M.",
                    "last": "Grey"
                },
                {
                    "first": "Jonathan W.",
                    "initial": "J.W.",
                    "last": "Yewdell"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Sette"
                }
            ],
            "doi": "10.1073/pnas.0506768102",
            "firstpage": "13980",
            "issn": "00278424",
            "lastpage": "13985",
            "pmid": "16172378",
            "pub_year": 2005,
            "title": "HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation",
            "volume": "102"
        },
        "bib0245": {
            "authors": [
                {
                    "first": "Magdalini",
                    "initial": "M.",
                    "last": "Moutaftsi"
                },
                {
                    "first": "Huynh Hoa",
                    "initial": "H.H.",
                    "last": "Bui"
                },
                {
                    "first": "Bjoern",
                    "initial": "B.",
                    "last": "Peters"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Sidney"
                },
                {
                    "first": "Shahram",
                    "initial": "S.",
                    "last": "Salek-Ardakani"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Oseroff"
                },
                {
                    "first": "Valerie",
                    "initial": "V.",
                    "last": "Pasquetto"
                },
                {
                    "first": "Shane",
                    "initial": "S.",
                    "last": "Crotty"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Croft"
                },
                {
                    "first": "Elliot J.",
                    "initial": "E.J.",
                    "last": "Lefkowitz"
                },
                {
                    "first": "Howard",
                    "initial": "H.",
                    "last": "Grey"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Sette"
                }
            ],
            "doi": "10.4049/jimmunol.178.11.6814",
            "firstpage": "6814",
            "issn": "00221767",
            "lastpage": "6820",
            "pmid": "17513729",
            "pub_year": 2007,
            "title": "Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses",
            "volume": "178"
        },
        "bib0250": {
            "authors": [
                {
                    "first": "Tomoya",
                    "initial": "T.",
                    "last": "Saito"
                },
                {
                    "first": "Tatsuya",
                    "initial": "T.",
                    "last": "Fujii"
                },
                {
                    "first": "Yasuhiro",
                    "initial": "Y.",
                    "last": "Kanatani"
                },
                {
                    "first": "Shigeru",
                    "initial": "S.",
                    "last": "Morikawa"
                },
                {
                    "first": "Hiroyuki",
                    "initial": "H.",
                    "last": "Yokote"
                },
                {
                    "first": "Tsutomu",
                    "initial": "T.",
                    "last": "Takeuchi"
                },
                {
                    "first": "Noriyuki",
                    "initial": "N.",
                    "last": "Kuwabara"
                }
            ],
            "doi": "10.1001/jama.2009.289",
            "firstpage": "1025",
            "issn": "00987484",
            "lastpage": "1033",
            "pmid": "19278946",
            "pub_year": 2009,
            "title": "Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8",
            "volume": "301"
        },
        "bib0255": {
            "authors": [
                {
                    "first": "Jeffrey S.",
                    "initial": "J.S.",
                    "last": "Kennedy"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Gurwith"
                },
                {
                    "first": "Cornelia L.",
                    "initial": "C.L.",
                    "last": "Dekker"
                },
                {
                    "first": "Sharon E.",
                    "initial": "S.E.",
                    "last": "Frey"
                },
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Edwards"
                },
                {
                    "first": "Julie",
                    "initial": "J.",
                    "last": "Kenner"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Lock"
                },
                {
                    "first": "Cyril",
                    "initial": "C.",
                    "last": "Empig"
                },
                {
                    "first": "Shigeru",
                    "initial": "S.",
                    "last": "Morikawa"
                },
                {
                    "first": "Masayuki",
                    "initial": "M.",
                    "last": "Saijo"
                },
                {
                    "first": "Hiroyuki",
                    "initial": "H.",
                    "last": "Yokote"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Karem"
                },
                {
                    "first": "Inger",
                    "initial": "I.",
                    "last": "Damon"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Perlroth"
                },
                {
                    "first": "Richard N.",
                    "initial": "R.N.",
                    "last": "Greenberg"
                }
            ],
            "doi": "10.1093/infdis/jir527",
            "firstpage": "1395",
            "issn": "00221899",
            "lastpage": "1402",
            "pmid": "21921208",
            "pub_year": 2011,
            "title": "Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults",
            "volume": "204"
        },
        "bib0260": {
            "authors": [
                {
                    "first": "Shari N.",
                    "initial": "S.N.",
                    "last": "Gordon"
                },
                {
                    "first": "Valentina",
                    "initial": "V.",
                    "last": "Cecchinato"
                },
                {
                    "first": "Vibeke",
                    "initial": "V.",
                    "last": "Andresen"
                },
                {
                    "first": "Jean Michel",
                    "initial": "J.M.",
                    "last": "Heraud"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Hryniewicz"
                },
                {
                    "first": "Robyn Washington",
                    "initial": "R.W.",
                    "last": "Parks"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Venzon"
                },
                {
                    "first": "Hye Kyung",
                    "initial": "H.K.",
                    "last": "Chung"
                },
                {
                    "first": "Tatiana",
                    "initial": "T.",
                    "last": "Karpova"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "McNally"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Silvera"
                },
                {
                    "first": "Keith A.",
                    "initial": "K.A.",
                    "last": "Reimann"
                },
                {
                    "first": "Hajime",
                    "initial": "H.",
                    "last": "Matsui"
                },
                {
                    "first": "Tomomi",
                    "initial": "T.",
                    "last": "Kanehara"
                },
                {
                    "first": "Yasuhiko",
                    "initial": "Y.",
                    "last": "Shinmura"
                },
                {
                    "first": "Hiroyuki",
                    "initial": "H.",
                    "last": "Yokote"
                },
                {
                    "first": "Genoveffa",
                    "initial": "G.",
                    "last": "Franchini"
                }
            ],
            "doi": "10.1093/infdis/jiq162",
            "firstpage": "1043",
            "issn": "00221899",
            "lastpage": "1053",
            "pmid": "21450994",
            "pub_year": 2011,
            "title": "Smallpox vaccine safety is dependent on T cells and not B cells",
            "volume": "203"
        },
        "bib0265": {
            "authors": [
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Stitz"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Althage"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Hengartner"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Zinkernagel"
                }
            ],
            "firstpage": "598",
            "issn": "00221767",
            "lastpage": "602",
            "pmid": "2981094",
            "pub_year": 1985,
            "title": "Natural killer cells vs cytotoxic T cells in the peripheral blood of virus-infected mice",
            "volume": "134"
        },
        "bib0270": {
            "authors": [
                {
                    "first": "Shizuo",
                    "initial": "S.",
                    "last": "Akira"
                },
                {
                    "first": "Satoshi",
                    "initial": "S.",
                    "last": "Uematsu"
                },
                {
                    "first": "Osamu",
                    "initial": "O.",
                    "last": "Takeuchi"
                }
            ],
            "doi": "10.1016/j.cell.2006.02.015",
            "firstpage": "783",
            "issn": "00928674",
            "lastpage": "801",
            "pmid": "16497588",
            "pub_year": 2006,
            "title": "Pathogen recognition and innate immunity",
            "volume": "124"
        },
        "bib0275": {
            "authors": [
                {
                    "first": "April Keim",
                    "initial": "A.K.",
                    "last": "Parker"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Parker"
                },
                {
                    "first": "Wayne M.",
                    "initial": "W.M.",
                    "last": "Yokoyama"
                },
                {
                    "first": "John A.",
                    "initial": "J.A.",
                    "last": "Corbett"
                },
                {
                    "first": "R. Mark L.",
                    "initial": "R.M.L.",
                    "last": "Buller"
                }
            ],
            "doi": "10.1128/JVI.02061-06",
            "firstpage": "4070",
            "issn": "0022538X",
            "lastpage": "4079",
            "pmid": "17287257",
            "pub_year": 2007,
            "title": "Induction of natural killer cell responses by ectromelia virus controls infection",
            "volume": "81"
        },
        "bib0280": {
            "authors": [
                {
                    "first": "Geoffrey L.",
                    "initial": "G.L.",
                    "last": "Smith"
                },
                {
                    "first": "Camilla T.O.",
                    "initial": "C.T.O.",
                    "last": "Benfield"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Maluquer de Motes"
                },
                {
                    "first": "Michela",
                    "initial": "M.",
                    "last": "Mazzon"
                },
                {
                    "first": "Stuart W.J.",
                    "initial": "S.W.J.",
                    "last": "Ember"
                },
                {
                    "first": "Brian J.",
                    "initial": "B.J.",
                    "last": "Ferguson"
                },
                {
                    "first": "Rebecca P.",
                    "initial": "R.P.",
                    "last": "Sumner"
                }
            ],
            "doi": "10.1099/vir.0.055921-0",
            "firstpage": "2367",
            "issn": "00221317",
            "lastpage": "2392",
            "pmid": "23999164",
            "pub_year": 2013,
            "title": "Vaccinia virus immune evasion: Mechanisms, virulence and immunogenicity",
            "volume": "94"
        }
    },
    "body_text": [
        {
            "endOffset": 26157,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "These results strongly suggest that innate immunity or CD8+ T-cell mediated immunity or both participate in protection by vaccination with LC16m8 and Lister.",
            "startOffset": 26000,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 27937,
            "parents": [],
            "refoffsets": {
                "bib0220": {
                    "endOffset": 27936,
                    "startOffset": 27932
                }
            },
            "secId": "sec0050",
            "sentence": "Recently, we studied the safety of LC16m8 in three immunodeficient mouse models (suckling mice, severe combined immunodeficient mice, and wild-type mice treated with cyclosporine) and showed that LC16m8 showed extremely low virulence in each of these mouse models when compared with its parental strains, Lister and LC16mO [16].",
            "startOffset": 27609,
            "title": "Discussion"
        },
        {
            "endOffset": 31579,
            "parents": [],
            "refoffsets": {
                "bib0255": {
                    "endOffset": 31578,
                    "startOffset": 31574
                }
            },
            "secId": "sec0050",
            "sentence": "Previously vaccinated healthy adults yield an effective booster response: a phase I/II clinical trial of LC16m8 vaccine achieved anti-vaccinia, anti-variola, and anti-monkeypox neutralizing antibody titers >1:40, and induced robust cellular immune responses as assessed by a lymphocyte proliferation test [23].",
            "startOffset": 31269,
            "title": "Discussion"
        },
        {
            "endOffset": 13079,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Among many pathogens that could be used potentially in bioterrorism, variola virus is one of the most recognized and the most feared.",
            "startOffset": 12946,
            "title": "Introduction"
        },
        {
            "endOffset": 25684,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "Innate immunity or CD4+ T cell-mediated immunity or both are suggested to participate in protection.",
            "startOffset": 25584,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 23006,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0040",
            "sentence": "When mice were challenged with WR on day 4 after vaccination, both LC16m8- and Lister-vaccinated mice showed neither severe nor continuous weight loss, but all non-vaccinated mice and half of ultraviolet (UV)-inactivated Lister vaccinated mice lost weight until they died (Fig. 1B).",
            "startOffset": 22724,
            "title": "Protection in wild-type mice by vaccination with LC16m8"
        },
        {
            "endOffset": 15528,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The B5R gene product, B5 protein, is a 42-KDa envelope glycoprotein composed of 317 amino acids.",
            "startOffset": 15432,
            "title": "Introduction"
        },
        {
            "endOffset": 23639,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0040",
            "sentence": "These results (1) showed that both LC16m8 attenuated by the defect of B5R gene and its parental strain Lister had comparable abilities to protect wild-type mice from very early stages to 1 year post-vaccination, and (2) implicated that vaccination with both LC16m8 and Lister conferred at least partial protective immunity on day 2 after vaccination, and almost complete protective immunity on day 4 or later until at least 1 year after vaccination.",
            "startOffset": 23190,
            "title": "Protection in wild-type mice by vaccination with LC16m8"
        },
        {
            "endOffset": 29700,
            "parents": [],
            "refoffsets": {
                "bib0240": {
                    "endOffset": 29699,
                    "startOffset": 29695
                }
            },
            "secId": "sec0050",
            "sentence": "A total of 49 epitopes recognized by CD8+ T-cells from 35 different VACV antigens were identified by screening with peripheral blood mononuclear cells of 31 vaccinees [20].",
            "startOffset": 29528,
            "title": "Discussion"
        },
        {
            "endOffset": 28058,
            "parents": [],
            "secId": "sec0050",
            "sentence": "These results, together with the results obtained in this study, open the way to use LC16m8 in immunodeficient patients.",
            "startOffset": 27938,
            "title": "Discussion"
        },
        {
            "endOffset": 21586,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "After 4 days of incubation, the number of observed plaques was counted.",
            "startOffset": 21515,
            "title": "Plaque reduction neutralizing (PRN) assay"
        },
        {
            "endOffset": 34183,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Induction of innate immunity by live LC16m8 virus is considered to activate cell-mediated and humoral immunity, as shown by good protection of mice against lethal challenge by at least 1 year after vaccination (Figs. 1, 2).",
            "startOffset": 33960,
            "title": "Discussion"
        },
        {
            "endOffset": 14867,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The LC16m8 vaccine is now produced by the Chemo-Sero-Therapeutic Research Institute (Kaketsuken), Japan, and is stockpiled as a smallpox vaccine against bioterrorism in Japan.",
            "startOffset": 14692,
            "title": "Introduction"
        },
        {
            "endOffset": 22723,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0040",
            "sentence": "Non-vaccinated mice lost weight continuously, culminating in death by day 11 after the challenge (Fig. 1A).",
            "startOffset": 22616,
            "title": "Protection in wild-type mice by vaccination with LC16m8"
        },
        {
            "endOffset": 18853,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "The WR VACV strain (ATCC VR-1354) used for the challenge was purchased from the American Type Culture Collection (ATCC).",
            "startOffset": 18733,
            "title": "Vaccine and virus strains"
        },
        {
            "endOffset": 24976,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "Second, the effect on MHC class I-deficient mice was evaluated by challenging with 105 PFU WR/mouse at 3 weeks after vaccination (Fig. 3B).",
            "startOffset": 24837,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 19993,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "After vaccination, the mice were challenged intranasally with a dose of 105 PFU/mouse or 106 PFU/mouse WR viruses, either of which was amply lethal, at appropriate time point after vaccination in order to achieve a highly-lethal condition in the non-immunized animals per each model.",
            "startOffset": 19710,
            "title": "Vaccination and WR challenge"
        },
        {
            "endOffset": 33245,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Vaccination with LC16m8 or Lister induced comparable partial protection in MHC class I- and II-double deficient mice lacking both T-cell- and B-cell-mediated immunity and strongly supports the above speculation of the contribution of innate immunity to immediate protection (Fig. 3D).",
            "startOffset": 32961,
            "title": "Discussion"
        },
        {
            "endOffset": 23190,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0040",
            "sentence": "All mice challenged with WR at 3 weeks, 24 weeks and 1 year after single dose vaccination showed almost the same results as for mice challenged on day 4 after vaccination (Fig. 1C\u2013E).",
            "startOffset": 23007,
            "title": "Protection in wild-type mice by vaccination with LC16m8"
        },
        {
            "endOffset": 33960,
            "parents": [],
            "refoffsets": {
                "bib0270": {
                    "endOffset": 33959,
                    "startOffset": 33955
                }
            },
            "secId": "sec0050",
            "sentence": "Several classes of these receptors, including Toll-like receptors and cytoplasmic receptors, recognize distinct microbial components and induce the release of interferon-\u03b1 and interferon-\u03b2 [26].",
            "startOffset": 33766,
            "title": "Discussion"
        },
        {
            "endOffset": 17512,
            "parents": [],
            "secId": "sec0005",
            "sentence": "To address this problem, this study investigated if LC16m8 with truncated B5 protein has immunological and protective activity comparable to that of its parental strain Lister by using wild-type and immunodeficient mice lacking CD4, MHC class I, MHC class II antigen or MHC class I and II antigens.",
            "startOffset": 17214,
            "title": "Introduction"
        },
        {
            "endOffset": 33613,
            "parents": [],
            "refoffsets": {
                "bib0265": {
                    "endOffset": 33379,
                    "startOffset": 33375
                }
            },
            "secId": "sec0050",
            "sentence": "Mice infected with various viruses, including VACV, induce natural killer (NK) cell activity on day 1 to day 10 after vaccination [25] and is consistent with the speculation from our results that protective activity of LC16m8 observed at the early stages after vaccination in wild-type mice and in various immunodeficient mice is given by innate immunity (Figs. 1, 3).",
            "startOffset": 33245,
            "title": "Discussion"
        },
        {
            "endOffset": 22202,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0040",
            "sentence": "Fig. 1 shows the survival and body weight of wild-type mice challenged intranasally with 105 PFU of WR virus on day 2 (A) or on day 4 (B), with 106 PFU of WR at 3 weeks (C), 24 weeks (D) and 1 year (E) after vaccination.",
            "startOffset": 21982,
            "title": "Protection in wild-type mice by vaccination with LC16m8"
        },
        {
            "endOffset": 12810,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The success of smallpox eradication by the World Health Organization (WHO) program in the 1970s is a landmark in the history of biomedical science.",
            "startOffset": 12663,
            "title": "Introduction"
        },
        {
            "endOffset": 14332,
            "parents": [],
            "secId": "sec0005",
            "sentence": "A rabbit skin proliferation study and a neurovirulence study in which LC16m8 and Lister viruses were inoculated into the thalamus of cynomolgus monkeys showed very low pathogenicity of LC16m8 compared with Lister.",
            "startOffset": 14119,
            "title": "Introduction"
        },
        {
            "endOffset": 25137,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "All mice vaccinated with LC16m8, live Lister virus or UV-inactivated Lister virus survived; mice vaccinated with Lister and LC16m8 showed almost no weight loss.",
            "startOffset": 24977,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 24455,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "Table 2 shows the survival ratio of each group, in which the number of mice (5 or 10) in each group is indicated.",
            "startOffset": 24342,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 29044,
            "parents": [],
            "secId": "sec0050",
            "sentence": "However, we use a vaccine preparation with a limited number of propagation to lessen this risk.",
            "startOffset": 28949,
            "title": "Discussion"
        },
        {
            "endOffset": 31074,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Although neutralizing antibody titers in CD4-deficient mice and MHC class I-deficient mice were not examined in the present study, if these results are obtained in the future, the results may strengthen our hypothesis.",
            "startOffset": 30856,
            "title": "Discussion"
        },
        {
            "endOffset": 30672,
            "parents": [],
            "secId": "sec0050",
            "sentence": "From the results that CD4-deficient mice, MHC class I-deficient mice and MHC class II-deficient mice were protected for at least 14 days after the challenge (Fig. 3A\u2013C), one or a combination of humoral, CD4+ T-cell-mediated and CD8+ T-cell-mediated immunity is suggested to be enough for protection.",
            "startOffset": 30373,
            "title": "Discussion"
        },
        {
            "endOffset": 13876,
            "parents": [],
            "refoffsets": {
                "bib0165": {
                    "endOffset": 13702,
                    "startOffset": 13697
                },
                "bib0170": {
                    "endOffset": 13702,
                    "startOffset": 13697
                }
            },
            "secId": "sec0005",
            "sentence": "In the early 1970s, Hashizume et al. [5,6], developed one of the safest replication-competent vaccines, LC16m8 strain, from the Lister (Elstree) strain that was used worldwide in the WHO smallpox eradication program.",
            "startOffset": 13660,
            "title": "Introduction"
        },
        {
            "endOffset": 28241,
            "parents": [],
            "refoffsets": {
                "bib0225": {
                    "endOffset": 28240,
                    "startOffset": 28236
                }
            },
            "secId": "sec0050",
            "sentence": "Relevant to this, a notable wide epidemic of monkeypox was reported in areas of west and central Africa where a high prevalence of human immunodeficiency virus infection exists [17].",
            "startOffset": 28059,
            "title": "Discussion"
        },
        {
            "endOffset": 26985,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "In this series of experiments, neutralizing antibodies to VACV WR were undetected at 14 days after WR challenge in immunized MHC class II-deficient and immunized MHC class I and II-double deficient mice (limit of detection, 1:8) (data not shown).",
            "startOffset": 26739,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 32960,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Our study also strongly suggested that LC16m8 induced innate immunity partially contributing to protection at the early stages after vaccination because vaccination with LC16m8 protected wild-type mice challenged on 2 to 4 days after vaccination (Fig. 1A, B): humoral, as well as CD4+ and CD8+ T-cell mediated, immune responses, if any, may not be induced or are very poor in these stages.",
            "startOffset": 32571,
            "title": "Discussion"
        },
        {
            "endOffset": 17696,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Immunological and protective activity was assessed in intranasally challenged mice with a lethal dose of a highly pathogenic vaccinia virus (VACV) strain, Western Reserve (WR) strain.",
            "startOffset": 17513,
            "title": "Introduction"
        },
        {
            "endOffset": 18972,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Wild-type BALB/c mice (female, 4 or 8-week old) were purchased from Charles River Laboratories Japan (Kanagawa).",
            "startOffset": 18860,
            "title": "Mice"
        },
        {
            "endOffset": 19634,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Groups of wild-type or immunodeficient mice received a single vaccination at 2.5 \u00d7 105 PFU/mouse of LC16m8 or Lister virus by a 15 times-puncture by using standard bifurcated needles at the base of the tail or a single intraperitoneal vaccination with UV-inactivated Lister virus (the virus titer before inactivation was 1 \u00d7 107 PFU/mouse).",
            "startOffset": 19294,
            "title": "Vaccination and WR challenge"
        },
        {
            "endOffset": 31114,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Other clinical studies support our view.",
            "startOffset": 31074,
            "title": "Discussion"
        },
        {
            "endOffset": 30373,
            "parents": [],
            "secId": "sec0050",
            "sentence": "To conclude, even if LC16m8 fails to induce a neutralizing antibody against B5 protein, both cell-mediated and humoral immune responses directed to many antigens other than B5 protein of large-size VACV should fully compensate the defect of LC16m8 because of truncated B5 protein.",
            "startOffset": 30093,
            "title": "Discussion"
        },
        {
            "endOffset": 26739,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "Notably, live LC16m8 and Lister showed significant partial protection, strongly suggesting that innate immunity contributes to protection.",
            "startOffset": 26601,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 20973,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "bib0185": {
                    "endOffset": 20972,
                    "startOffset": 20969
                }
            },
            "secId": "sec0030",
            "sentence": "This virus fluid may contain mainly intracellular mature viruses, with some other virus forms such as intracellular enveloped viruses, cell-associated enveloped viruses and extracellular enveloped viruses [9].",
            "startOffset": 20764,
            "title": "Plaque reduction neutralizing (PRN) assay"
        },
        {
            "endOffset": 30092,
            "parents": [],
            "refoffsets": {
                "bib0235": {
                    "endOffset": 30091,
                    "startOffset": 30087
                }
            },
            "secId": "sec0050",
            "sentence": "Interestingly, antibodies against the A33 surface protein are protective, but are not neutralizing [19].",
            "startOffset": 29988,
            "title": "Discussion"
        },
        {
            "endOffset": 33765,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Microorganisms, like viruses that invade a vertebrate host, are initially recognized by the innate immune system through pattern-recognition receptors.",
            "startOffset": 33614,
            "title": "Discussion"
        },
        {
            "endOffset": 32118,
            "parents": [],
            "secId": "sec0050",
            "sentence": "However, while depletion of both CD4+ and CD8+ T cells had no adverse effects on LC16m8-vaccinated animals, it caused disseminated vaccinia in macaques immunized with Dryvax.",
            "startOffset": 31944,
            "title": "Discussion"
        },
        {
            "endOffset": 32386,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Furthermore, as both Dryvax and LC16m8 vaccines protect healthy macaques from a lethal monkeypox intravenous challenge, their data identify LC16m8 as a safer and effective alternative to ACAM2000 and Dryvax vaccines for both healthy and immunocompromised individuals.",
            "startOffset": 32119,
            "title": "Discussion"
        },
        {
            "endOffset": 13660,
            "parents": [],
            "refoffsets": {
                "bib0145": {
                    "endOffset": 13551,
                    "startOffset": 13546
                },
                "bib0150": {
                    "endOffset": 13551,
                    "startOffset": 13546
                },
                "bib0155": {
                    "endOffset": 13659,
                    "startOffset": 13654
                },
                "bib0160": {
                    "endOffset": 13659,
                    "startOffset": 13654
                }
            },
            "secId": "sec0005",
            "sentence": "However, replication-competent vaccine strains derived from the NYCBH strain may have a side effect of inducing myopericarditis [1,2], and replication-incompetent viruses may have the potential problem of relatively poor immunogenicity [3,4].",
            "startOffset": 13418,
            "title": "Introduction"
        },
        {
            "endOffset": 25583,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "These results suggest that immune mechanisms independent of MHC class I antigens contribute to the elicitation of a protective response in mice vaccinated with LC16m8 and Lister, and live replicating virus is more effective in protection than inactivated non-replicating virus.",
            "startOffset": 25306,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 30855,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Poor protection of MHC class I and II-double deficient mice (Fig. 3D) suggests that either CD4+ T-cell-mediated immunity or CD8+ T-cell-mediated immunity is essential for protection.",
            "startOffset": 30673,
            "title": "Discussion"
        },
        {
            "endOffset": 24341,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "To study this possibility, we investigated the effect of LC16m8 vaccination by using various immunodeficient mice.",
            "startOffset": 24227,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 29527,
            "parents": [],
            "refoffsets": {
                "bib0235": {
                    "endOffset": 29526,
                    "startOffset": 29522
                }
            },
            "secId": "sec0050",
            "sentence": "Antigens directed for protective immunity are considered to be numerous because of the large size of VACV [19].",
            "startOffset": 29416,
            "title": "Discussion"
        },
        {
            "endOffset": 29987,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Five known neutralizing antibody target antigens exist: L1, H3, A27, D8 and B5.",
            "startOffset": 29908,
            "title": "Discussion"
        },
        {
            "endOffset": 20325,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Statistical analysis on mean survival time was done using the log rank method.",
            "startOffset": 20247,
            "title": "Vaccination and WR challenge"
        },
        {
            "endOffset": 25823,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "Third, the effect on MHC-class II-deficient mice was evaluated by challenging with 106 PFU WR/mouse at 2 weeks after vaccination (Fig. 3C).",
            "startOffset": 25684,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 28690,
            "parents": [],
            "refoffsets": {
                "bib0205": {
                    "endOffset": 28689,
                    "startOffset": 28685
                }
            },
            "secId": "sec0050",
            "sentence": "People vaccinated with LC16m8 induce neither extracellular enveloped virus-neutralizing antibody nor other kinds of antibody to B5 protein, even though after vaccination the neutralizing antibody to B5 protein is boosted in previously vaccinated individuals [13].",
            "startOffset": 28427,
            "title": "Discussion"
        },
        {
            "endOffset": 24837,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "By day 6 after the challenge, more than 70% of non-vaccinated mice had severe weight loss and died, while all LC16m8-vaccinated mice survived, suggesting that mice were protected by innate immunity or CD8+ T-cell mediated immunity or both.",
            "startOffset": 24598,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 21916,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "The neutralizing antibody titer was calculated based on the plaque number by using the Probit analysis method with Minitab software (Kozo Keikaku Engineering Inc., Tokyo) and was defined as the reciprocal of the dilution level resulting in a 50% reduction of total plaques formed by WR virus with no treatment by vaccinated sera.",
            "startOffset": 21587,
            "title": "Plaque reduction neutralizing (PRN) assay"
        },
        {
            "endOffset": 29907,
            "parents": [],
            "refoffsets": {
                "bib0245": {
                    "endOffset": 29906,
                    "startOffset": 29902
                }
            },
            "secId": "sec0050",
            "sentence": "By using a random peptide library, 14 epitopes recognized by CD4+ T-cells were identified [21].",
            "startOffset": 29812,
            "title": "Discussion"
        },
        {
            "endOffset": 18550,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "The Lister (Elstree) VACV strain, which was used for the WHO smallpox eradication program, and the parental strain of the LC16m8 strain were transferred to Kaketsuken from the Chiba Serum Institute (Chiba) when this institute closed.",
            "startOffset": 18317,
            "title": "Vaccine and virus strains"
        },
        {
            "endOffset": 20070,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "The mice were observed and weighed each day for 14 days after the challenge.",
            "startOffset": 19994,
            "title": "Vaccination and WR challenge"
        },
        {
            "endOffset": 16114,
            "parents": [],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 16113,
                    "startOffset": 16109
                }
            },
            "secId": "sec0005",
            "sentence": "The analysis of the full-genome sequence of LC16m8 and its parental strain Lister showed that LC16m8 preserved almost of all the open reading frames of vaccinia virus except for the disrupted EEV protein B5 [10].",
            "startOffset": 15902,
            "title": "Introduction"
        },
        {
            "endOffset": 23931,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0040",
            "sentence": "The neutralizing antibody titers against vaccinia WR virus were almost not detectable on days 2 to 6 after vaccination (data not shown), but then increased rapidly until 3 weeks, reaching a plateau from 8 weeks to 1 year after vaccination in both LC16m8- and Lister- vaccinated mice (Fig. 2).",
            "startOffset": 23639,
            "title": "Protection in wild-type mice by vaccination with LC16m8"
        },
        {
            "endOffset": 29415,
            "parents": [],
            "refoffsets": {
                "bib0230": {
                    "endOffset": 29414,
                    "startOffset": 29407
                },
                "bib0235": {
                    "endOffset": 29414,
                    "startOffset": 29407
                }
            },
            "secId": "sec0050",
            "sentence": "Not only humoral immunity, but also cell-mediated immunity, contribute to protection against poxvirus infection [18,19].",
            "startOffset": 29295,
            "title": "Discussion"
        },
        {
            "endOffset": 20419,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "All mice studies were approved by the Kaketsuken Institutional Animal Care and Use Committee.",
            "startOffset": 20326,
            "title": "Vaccination and WR challenge"
        },
        {
            "endOffset": 22424,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0040",
            "sentence": "Both vaccinated and non-vaccinated mice challenged with WR on day 2 after vaccination showed weight loss.",
            "startOffset": 22319,
            "title": "Protection in wild-type mice by vaccination with LC16m8"
        },
        {
            "endOffset": 25305,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "However, non-vaccinated mice had severe weight loss, and mice vaccinated with inactivated Lister virus had mild weight loss between >5 and 11 days after the challenge.",
            "startOffset": 25138,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 26454,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "All non-vaccinated mice died, while 70% and 60% of mice vaccinated with LC16m8 and Lister, respectively, survived until 14 days after the challenge.",
            "startOffset": 26306,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 15431,
            "parents": [],
            "refoffsets": {
                "bib0180": {
                    "endOffset": 15311,
                    "startOffset": 15308
                }
            },
            "secId": "sec0005",
            "sentence": "A molecular biological study showed that one gene of envelope proteins is defective, contributing to smaller plaque size and host range and was accordingly called as ps/hr) gene [8]: the ps/hr gene is a homologue of B5R gene of Copenhagen (CPN) strain, and now this gene is usually called as B5R gene.",
            "startOffset": 15130,
            "title": "Introduction"
        },
        {
            "endOffset": 15901,
            "parents": [],
            "secId": "sec0005",
            "sentence": "B5 protein is necessary for the formation of EEV, and therefore LC16m8 does not form EEV resulting in small-plaque size and less spreading ability, which is considered to mainly attribute to its attenuated properties.",
            "startOffset": 15684,
            "title": "Introduction"
        },
        {
            "endOffset": 28426,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Of concern is that LC16m8 with truncated B5 protein might have less immunogenicity and poor protective activity.",
            "startOffset": 28314,
            "title": "Discussion"
        },
        {
            "endOffset": 32571,
            "parents": [],
            "secId": "sec0050",
            "sentence": "This study strongly support the idea that CD4+ and CD8+ T cell- immunity plays crucial roles in protective ability, and that the lack of normal B5 protein does not affect this ability.",
            "startOffset": 32387,
            "title": "Discussion"
        },
        {
            "endOffset": 12945,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Since the terrorist attack on the World Trade Center in New York in September 2001, however, concern about bioterrorism has increased.",
            "startOffset": 12811,
            "title": "Introduction"
        },
        {
            "endOffset": 21514,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "The mixtures were inoculated in VeroE6 cell (ATCC CRL-1586, purchased from ATCC) monolayers in 12-well culture plates and were incubated in EMEM containing 3% FBS and 0.8% agarose ME (Iwai Chemicals Company, Tokyo) after 2 h of adsorption.",
            "startOffset": 21275,
            "title": "Plaque reduction neutralizing (PRN) assay"
        },
        {
            "endOffset": 18128,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "The vaccine lot used in this study is one (Lot V06) of the lots of smallpox vaccine stockpiled now in Japan against bioterrorism using smallpox.",
            "startOffset": 17984,
            "title": "Vaccine and virus strains"
        },
        {
            "endOffset": 13417,
            "parents": [],
            "refoffsets": {
                "bib0145": {
                    "endOffset": 13312,
                    "startOffset": 13307
                },
                "bib0150": {
                    "endOffset": 13312,
                    "startOffset": 13307
                },
                "bib0155": {
                    "endOffset": 13416,
                    "startOffset": 13411
                },
                "bib0160": {
                    "endOffset": 13416,
                    "startOffset": 13411
                }
            },
            "secId": "sec0005",
            "sentence": "Under such circumstances, serious attempts have been made to restart the development of vaccine strains, including a vaccinia ACAM2000 clone established from Dryvax derived from the New York City Board of Health (NYCBH) strain [1,2], modified vaccinia Ankara (MVA) and replication-incompetent viruses derived from the NYCBH strain [3,4].",
            "startOffset": 13080,
            "title": "Introduction"
        },
        {
            "endOffset": 14022,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Freeze-dried live attenuated smallpox vaccine of LC16m8 prepared in cell culture has been the sole smallpox vaccine licensed in Japan since 1975.",
            "startOffset": 13877,
            "title": "Introduction"
        },
        {
            "endOffset": 16386,
            "parents": [],
            "refoffsets": {
                "bib0195": {
                    "endOffset": 16385,
                    "startOffset": 16381
                }
            },
            "secId": "sec0005",
            "sentence": "A truncated B5 protein (approximately 8 kDa) was expressed abundantly in LC16m8-infected cells, and both murine immune sera and human vaccinia virus immunoglobulin recognized the truncated recombinant B5 protein in antigen-specific enzyme-linked immunosorbent assays [11].",
            "startOffset": 16114,
            "title": "Introduction"
        },
        {
            "endOffset": 28313,
            "parents": [],
            "refoffsets": {
                "bib0180": {
                    "endOffset": 28312,
                    "startOffset": 28306
                },
                "bib0190": {
                    "endOffset": 28312,
                    "startOffset": 28306
                }
            },
            "secId": "sec0050",
            "sentence": "The B5R gene defect is the major factor in attenuation of LC16m8 [8,10].",
            "startOffset": 28241,
            "title": "Discussion"
        },
        {
            "endOffset": 20582,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "The level of neutralizing antibody against vaccinia WR virus in the serum samples was assessed by PRN assay as follows.",
            "startOffset": 20463,
            "title": "Plaque reduction neutralizing (PRN) assay"
        },
        {
            "endOffset": 31943,
            "parents": [],
            "secId": "sec0050",
            "sentence": "B cell depletion did not affect the size of skin lesions induced by either vaccine.",
            "startOffset": 31860,
            "title": "Discussion"
        },
        {
            "endOffset": 31730,
            "parents": [],
            "refoffsets": {
                "bib0260": {
                    "endOffset": 31597,
                    "startOffset": 31593
                }
            },
            "secId": "sec0050",
            "sentence": "Gordon et al. [24] investigated the immunologic basis of the containment of vaccinia in the skin with the goal to identify safer vaccines for smallpox.",
            "startOffset": 31579,
            "title": "Discussion"
        },
        {
            "endOffset": 17214,
            "parents": [],
            "secId": "sec0005",
            "sentence": "This point is important in relation to the problem of whether LC16m8 is usable in areas of Africa where many immunodeficient patients, such as human immunodeficiency virus-infected patients, live.",
            "startOffset": 17018,
            "title": "Introduction"
        },
        {
            "endOffset": 27609,
            "parents": [],
            "refoffsets": {
                "bib0200": {
                    "endOffset": 27608,
                    "startOffset": 27604
                }
            },
            "secId": "sec0050",
            "sentence": "Notably, no difference existed between total neutralizing antibody titers induced with LC16m8 and Lister in wild-type mice (Fig. 2), MHC class II-deficient and MHC class I- and II- double deficient mice, despite the failure of LC16m8 to induce anti-B5 neutralizing antibody that is protective in mice [12].",
            "startOffset": 27303,
            "title": "Discussion"
        },
        {
            "endOffset": 20763,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "WR-virus infected Vero E6 cells (ATCC CRL-1586, purchased from ATCC) received three times repeated freeze-thaw and the resultant crude virus fluid was used as a source of WR virus.",
            "startOffset": 20583,
            "title": "Plaque reduction neutralizing (PRN) assay"
        },
        {
            "endOffset": 24597,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "First, the vaccination effect on CD4-deficient mice was evaluated by challenging with 106 PFU WR/mouse at 3 weeks after vaccination (Fig. 3A).",
            "startOffset": 24455,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 15683,
            "parents": [],
            "refoffsets": {
                "bib0185": {
                    "endOffset": 15682,
                    "startOffset": 15679
                }
            },
            "secId": "sec0005",
            "sentence": "Vaccinia virus produces two typical types of virion from each infected cell called intracellular mature virus and extracellular enveloped virus (EEV) [9].",
            "startOffset": 15529,
            "title": "Introduction"
        },
        {
            "endOffset": 16746,
            "parents": [],
            "refoffsets": {
                "bib0205": {
                    "endOffset": 16745,
                    "startOffset": 16741
                }
            },
            "secId": "sec0005",
            "sentence": "Furthermore, LC16m8 fails to induce enough anti-B5 antibody responses in the human [13].",
            "startOffset": 16658,
            "title": "Introduction"
        },
        {
            "endOffset": 29294,
            "parents": [],
            "secId": "sec0050",
            "sentence": "In addition to LC16m8 showing protective activity completely comparable to that of its parental strain Lister, the following immunological evidence strengthens the idea that the B5 protein defect does not affect all the protective activity of LC16m8.",
            "startOffset": 29044,
            "title": "Discussion"
        },
        {
            "endOffset": 34856,
            "parents": [],
            "secId": "sec0060",
            "sentence": "SH declares that he has no conflicts of interest.",
            "startOffset": 34807,
            "title": "Conflict of interest statement"
        },
        {
            "endOffset": 27302,
            "parents": [],
            "secId": "sec0050",
            "sentence": "This study showed that vaccine strain LC16m8 with truncated surface B5 protein has protective activity completely comparable to that of its parental strain Lister in all experiments using wild-type, CD4-deficient, MHC class I-deficient, MHC class II-deficient or MHC class I- and II- double deficient mice.",
            "startOffset": 26996,
            "title": "Discussion"
        },
        {
            "endOffset": 14691,
            "parents": [],
            "secId": "sec0005",
            "sentence": "No major differences exist in the immunogenicity of LC16m8 when compared with conventional first generation smallpox vaccines such as its parental vaccine strain Lister.",
            "startOffset": 14522,
            "title": "Introduction"
        },
        {
            "endOffset": 15130,
            "parents": [],
            "refoffsets": {
                "bib0175": {
                    "endOffset": 15008,
                    "startOffset": 15005
                }
            },
            "secId": "sec0005",
            "sentence": "According to the November 2013 conclusions and recommendations of the Meeting of the Strategic Advisory Group of Experts on immunization [7], both licensed ACAM2000 (2nd generation vaccine) and LC16m8 (3rd generation vaccine) are preferred for the WHO stockpile.",
            "startOffset": 14868,
            "title": "Introduction"
        },
        {
            "endOffset": 31268,
            "parents": [],
            "refoffsets": {
                "bib0250": {
                    "endOffset": 31266,
                    "startOffset": 31262
                }
            },
            "secId": "sec0050",
            "sentence": "Administration of LC16m8 to healthy adults who were vaccinia-na\u00efve is associated with high levels of vaccine take and seroconversion (Saito et al. [22]).",
            "startOffset": 31115,
            "title": "Discussion"
        },
        {
            "endOffset": 17017,
            "parents": [],
            "refoffsets": {
                "bib0170": {
                    "endOffset": 16928,
                    "startOffset": 16919
                },
                "bib0190": {
                    "endOffset": 16928,
                    "startOffset": 16919
                },
                "bib0210": {
                    "endOffset": 16928,
                    "startOffset": 16919
                }
            },
            "secId": "sec0005",
            "sentence": "Although previous studies showed that in normal animals and humans LC16m8 keeps strong immunological and protective activity comparable to that of its parent strain Lister [6,10,14], whether it keeps such activity also in immunodeficient animals remains to be clarified.",
            "startOffset": 16747,
            "title": "Introduction"
        },
        {
            "endOffset": 19709,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "See Table 1 and Table 2 for the number of mice in each experimental group.",
            "startOffset": 19635,
            "title": "Vaccination and WR challenge"
        },
        {
            "endOffset": 18316,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "bib0215": {
                    "endOffset": 18247,
                    "startOffset": 18243
                }
            },
            "secId": "sec0015",
            "sentence": "In the current manufacturing process, the occurrence of B5R revertant virus which was reported by Kidokoro et al. [15] was well controlled and the content rate in the Lot V06 is under 1%.",
            "startOffset": 18129,
            "title": "Vaccine and virus strains"
        },
        {
            "endOffset": 14118,
            "parents": [],
            "refoffsets": {
                "bib0170": {
                    "endOffset": 14117,
                    "startOffset": 14114
                }
            },
            "secId": "sec0005",
            "sentence": "LC16m8 was selected as a temperature- sensitive small-plaque- and small-pock-forming clone [6].",
            "startOffset": 14023,
            "title": "Introduction"
        },
        {
            "endOffset": 18732,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "UV-inactivated Lister virus was prepared by placing 1 \u00d7 107 PFU/mL of Lister virus under UV lumps for approximately 18 h and the inactivation was confirmed by standard plaque assay.",
            "startOffset": 18551,
            "title": "Vaccine and virus strains"
        },
        {
            "endOffset": 17983,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Freeze-dried smallpox vaccine (LC16-KAKETSUKEN; LC16m8) manufactured under good manufacturing practice (GMP)-compliant condition by Kaketsuken in cell culture using primary rabbit kidney cells was used as the source of LC16m8 VACV strain.",
            "startOffset": 17745,
            "title": "Vaccine and virus strains"
        },
        {
            "endOffset": 22319,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0040",
            "sentence": "Table 1 shows the survival ratio of each group, in which the number of mice (5, 6 or 10) in each group is indicated.",
            "startOffset": 22203,
            "title": "Protection in wild-type mice by vaccination with LC16m8"
        },
        {
            "endOffset": 21274,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "WR virus at 240 PFU in 0.12 mL of Eagle's minimal essential medium (EMEM) (Nissui, Tokyo) containing 1% fetal bovine serum (FBS) (Life Technologies, Maryland) was mixed with 0.12 mL of serially diluted heat-inactivated serum samples collected from test animals and was incubated at 37 \u00b0C for 15\u201318 h.",
            "startOffset": 20974,
            "title": "Plaque reduction neutralizing (PRN) assay"
        },
        {
            "endOffset": 14521,
            "parents": [],
            "secId": "sec0005",
            "sentence": "A clinical evaluation of 90,000 infants immunized during the initial development of LC16m8 from 1973 to early 1976 showed no encephalitis or other serious adverse events after vaccination.",
            "startOffset": 14333,
            "title": "Introduction"
        },
        {
            "endOffset": 26600,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "All groups of mice had continuous weight loss until 14 days after the challenge, and especially non-vaccinated mice had the severest weight loss.",
            "startOffset": 26455,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 29811,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Fewer studies have been done to identify targets of VACV-specific CD4+ T-cells in the murine system (C57BL/6).",
            "startOffset": 29701,
            "title": "Discussion"
        },
        {
            "endOffset": 34722,
            "parents": [],
            "secId": "sec0055",
            "sentence": "This study strongly suggested that LC16m8 with truncated B5 protein has an activity to induce innate immunity and subsequent cell-mediated and humoral immunity almost completely comparable to the activity of its parental strain Lister.",
            "startOffset": 34487,
            "title": "Conclusion"
        },
        {
            "endOffset": 26305,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "Fourth, the effect on MHC class I- and II-double deficient mice was evaluated by challenging with 105 PFU WR at 2 weeks after vaccination (Fig. 3D).",
            "startOffset": 26157,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 34806,
            "parents": [],
            "secId": "sec0060",
            "sentence": "HY, YS, TK, SM, MK and HM are employees of Kaketsuken.",
            "startOffset": 34752,
            "title": "Conflict of interest statement"
        },
        {
            "endOffset": 31859,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Macaques were depleted systemically of T or B cells and vaccinated with either Dryvax or an attenuated vaccinia vaccine, LC16m8.",
            "startOffset": 31731,
            "title": "Discussion"
        },
        {
            "endOffset": 22615,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0040",
            "sentence": "Mice vaccinated with either LC16m8 or Lister lost weight from 2 to 6 days after the challenge, but they began to recover weight around days 7 and 8 after the challenge and they all survived.",
            "startOffset": 22425,
            "title": "Protection in wild-type mice by vaccination with LC16m8"
        },
        {
            "endOffset": 20246,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Mice that had showed severe weight loss and survived to the end of this study, that is, on day 14 after the challenge were euthanized by heart exsanguination under anesthesia.",
            "startOffset": 20071,
            "title": "Vaccination and WR challenge"
        },
        {
            "endOffset": 19263,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "The following immunodeficient mice (female, 4- to 7-week old) were purchased from the Taconic Farms (New York): Cd4 (001055-MF) CD4-deficient, B2 m (B2MN12-MF) MHC class I-deficient, Abb (ABBN12-MF) MHC class II-deficient, and Abb/\u03b22 m (004080-MMF) MHC class I and II-double deficient mice.",
            "startOffset": 18973,
            "title": "Mice"
        },
        {
            "endOffset": 25999,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "All mice vaccinated with LC16m8 or live Lister survived, but 40% of the mice vaccinated with inactivated Lister and 80% of non-vaccinated mice had severe weight loss and died.",
            "startOffset": 25824,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 28948,
            "parents": [],
            "refoffsets": {
                "bib0215": {
                    "endOffset": 28920,
                    "startOffset": 28916
                }
            },
            "secId": "sec0050",
            "sentence": "This boosting effect might be due to an abundant expression of a truncated B5 protein in LC16m8 as mentioned previously but the possibility of the occurrence of a revertant virus due to repair of the mutation in the B5R gene [15] is not completely excluded.",
            "startOffset": 28691,
            "title": "Discussion"
        },
        {
            "endOffset": 16657,
            "parents": [],
            "refoffsets": {
                "bib0200": {
                    "endOffset": 16656,
                    "startOffset": 16652
                }
            },
            "secId": "sec0005",
            "sentence": "Of major concern, however, is whether LC16m8 vaccine has enough immunogenicity to confer strong protection, because LC16m8 lacks normal type of the B5R gene product, B5 protein, which is a target epitope of neutralizing antibodies contributing to protection in mice [12].",
            "startOffset": 16386,
            "title": "Introduction"
        },
        {
            "endOffset": 24226,
            "parents": [
                {
                    "id": "sec0035",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "Because protection by vaccination with LC16m8 was shown in wild-type mice challenged with WR as early as 2 days after vaccination, we speculated the involvement of other immune mechanism as than humoral immunity in this protection.",
            "startOffset": 23995,
            "title": "Protection in immunodeficient mice by vaccination with LC16m8"
        },
        {
            "endOffset": 34476,
            "parents": [],
            "refoffsets": {
                "bib0275": {
                    "endOffset": 34475,
                    "startOffset": 34468
                },
                "bib0280": {
                    "endOffset": 34475,
                    "startOffset": 34468
                }
            },
            "secId": "sec0050",
            "sentence": "VACV antigens present on the cell surface induce acquired immunity, including humoral and T-cell-mediated immunity, whereas VACV antigens inside cells contribute to the production of interferons, pro-inflammatory cytokines and chemokines, and NK cells responsible for innate immunity [27,28].",
            "startOffset": 34184,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X15010543",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Hiroyuki",
                "initial": "H.",
                "last": "Yokote"
            },
            {
                "email": "shinmura-ya@kaketsuken.or.jp",
                "first": "Yasuhiko",
                "initial": "Y.",
                "last": "Shinmura"
            },
            {
                "email": null,
                "first": "Tomomi",
                "initial": "T.",
                "last": "Kanehara"
            },
            {
                "email": null,
                "first": "Shinichi",
                "initial": "S.",
                "last": "Maruno"
            },
            {
                "email": null,
                "first": "Masahiko",
                "initial": "M.",
                "last": "Kuranaga"
            },
            {
                "email": null,
                "first": "Hajime",
                "initial": "H.",
                "last": "Matsui"
            },
            {
                "email": null,
                "first": "So",
                "initial": "S.",
                "last": "Hashizume"
            }
        ],
        "doi": "10.1016/j.vaccine.2015.07.076",
        "firstpage": "6112",
        "issn": "0264410X",
        "keywords": [
            "Bioterrorism",
            "Efficacy evaluation study",
            "Immunodeficient subject",
            "LC16m8",
            "Smallpox vaccine",
            "WHO stockpile vaccine"
        ],
        "lastpage": "6119",
        "openaccess": "Full",
        "pub_year": 2015,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice"
    }
}